These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 16046298)

  • 1. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
    Wang Z; Jiang T; Li J; Proctor G; McManaman JL; Lucia S; Chua S; Levi M
    Diabetes; 2005 Aug; 54(8):2328-35. PubMed ID: 16046298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.
    Sun L; Halaihel N; Zhang W; Rogers T; Levi M
    J Biol Chem; 2002 May; 277(21):18919-27. PubMed ID: 11875060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.
    Jiang T; Wang Z; Proctor G; Moskowitz S; Liebman SE; Rogers T; Lucia MS; Li J; Levi M
    J Biol Chem; 2005 Sep; 280(37):32317-25. PubMed ID: 16046411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.
    Jiang T; Liebman SE; Lucia MS; Li J; Levi M
    Kidney Int; 2005 Dec; 68(6):2608-20. PubMed ID: 16316337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
    Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
    Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
    Jiang T; Liebman SE; Lucia MS; Phillips CL; Levi M
    J Am Soc Nephrol; 2005 Aug; 16(8):2385-94. PubMed ID: 15944339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.
    He L; Hao L; Fu X; Huang M; Li R
    BMC Nephrol; 2015 Apr; 16():51. PubMed ID: 25884847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Harima M; Suzuki K; Kawachi H; Watanabe K
    J Nutr Biochem; 2013 May; 24(5):796-802. PubMed ID: 22898567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability.
    Peng J; Yu J; Xu H; Kang C; Shaul PW; Guan Y; Zhang X; Su W
    Cell Physiol Biochem; 2018; 47(2):784-799. PubMed ID: 29807364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
    Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
    Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals.
    Chin HJ; Fu YY; Ahn JM; Na KY; Kim YS; Kim S; Chae DW
    Nephrol Dial Transplant; 2010 May; 25(5):1450-7. PubMed ID: 20042400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
    Shimano H; Horton JD; Hammer RE; Shimomura I; Brown MS; Goldstein JL
    J Clin Invest; 1996 Oct; 98(7):1575-84. PubMed ID: 8833906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.
    Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N
    J Biol Chem; 2002 May; 277(22):19353-7. PubMed ID: 11923308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.